Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Non-Interventional Study of PD-L1 Prevalence and Clinical Outcomes for Non-Small Cell Lung Cancer in Asia-Pacific

NCT03037086 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03037086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03037086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Non-Interventional Study of PD-L1 Prevalence and Clinical Outcomes for Non-Small Cell Lung Cancer in Asia-Pacific
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 15, 2015
Completion date
February 27, 2017
Enrollment
658 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic nsclc